Abbott Acquisition, PTV News: May 21, 2010

Episode Loading...

PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Abbott Acquisition, PTV News: May 21, 2010
Released on: May 21, 2010. © PharmaVentures Ltd
Visitors: You are watching a 1 minute preview.
Share/save this page:
Follow us:
  • Summary
  • Transcript
  • Participants
  • Company
Abbott buys Piramal's Healthcare Solutions for US $3.72B
Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.
Mel Hemamda
Senior Advisor

Mel is an experienced business advisor with expertise in evaluating and executing pharmaceutical business development opportunities. His current focus is in transaction management, where he is involved in managing simultaneous transaction projects on behalf of clients seeking to divest or acquire pharmaceutical assets. In this role, his responsibility includes value proposition development, driving the business development campaign and building deal structure scenarios. Mel is multilingual, holds a BSc. (Hons) in Business Management and an MBA from Oxford Brookes.
Abbott Laboratories
Abbott Laboratories is a diversified pharmaceuticals health care company. It has 72,000 employees and operates in over 130 countries. The corporate headquarters are in Abbott Park, Illinois, located near North Chicago, Illinois.

Abbott Laboratories was founded by Chicago physician Wallace Calvin Abbott in 1888. In 2008, Abbott had over $29 billion in revenue.
Piramal Healthcare
Piramal Healthcare Ltd, a Piramal Group company, is a globally integrated healthcare company that fulfills unmet medical needs across the world. It has a growth track record of above 29% CAGR since 1988.